Masahiro Sano
Nagoya, 4668550, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Utility of risk assessment and identification of risk factors for drug-resistant pathogens in hospital-acquired and ventilator-associated pneumonia: systematic reviews and meta-analyses.
Journal: Respiratory investigation
Published: October 28, 2025
Association between immunity and antimicrobial treatment resistance in patients with Mycobacterium avium complex pulmonary disease: a multicenter observational study.
Journal: BMC infectious diseases
Published: July 07, 2025
A case of community-acquired Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus (MRSA) necrotizing pneumonia successfully treated with two anti-MRSA drugs.
Journal: Respiratory medicine case reports
Published: January 17, 2024
Transthoracic lung biopsy: diagnostic accuracy and complications.
Journal: Translational cancer research
Published: November 26, 2022
Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: November 28, 2021
A prediction rule for severe adverse events in all inpatients with community-acquired pneumonia: a multicenter observational study.
Journal: BMC pulmonary medicine
Published: October 19, 2021
Clinical characteristics and risk factors for mortality in patients with community-acquired staphylococcal pneumonia.
Journal: Nagoya journal of medical science
Published: April 05, 2021
Extensive Lung Resection for Nontuberculous Mycobacterial Lung Disease With Multilobar Lesions.
Journal: The Annals of thoracic surgery
Published: February 05, 2020
A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.
Journal: Antimicrobial agents and chemotherapy
Published: July 24, 2018
Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy.
Journal: Respirology (Carlton, Vic.)
Published: March 29, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026